The association between blood pressure control in women during pregnancy and adverse perinatal outcomes: the TMM BirThree Cohort Study

Mami Ishikuro,Taku Obara,Keiko Murakami,Fumihiko Ueno,Aoi Noda,Tomomi Onuma,Masahiro Kikuya,Hirohito Metoki,Shinichi Kuriyama

DOI: https://doi.org/10.1038/s41440-023-01570-x

2024-01-19

Hypertension Research

Abstract:Blood pressure (BP) control in pregnancy is essential to prevent adverse outcomes. However, BP levels for hypertension treatment are inconsistent among various guidelines. This study investigated the association between BP control and adverse perinatal outcomes. A total of 18,155 mother-offspring pairs were classified into four groups according to BP after 20 gestational weeks: normal BP (<140/90 mmHg without antihypertensive drugs), high BP (≥140/90 mmHg without antihypertensive drugs), controlled BP (<140/90 mmHg with antihypertensive drugs), and uncontrolled BP (≥140/90 mmHg with antihypertensive drugs). The prevalence of small for gestational age was 1,087/17,476 offspring in normal BP, 78/604 in high BP, 5/42 in controlled BP, and 7/33 in uncontrolled BP. Compared to normal BP, adjusted odds ratios (ORs) (95% confidence intervals (CIs)) were 1.76 (1.32–2.35) for high BP, 2.08 (0.79–5.50) for controlled BP, and 2.34 (0.94–5.85) for uncontrolled BP (multiple logistic regression analysis). Similarly, the adjusted ORs (95% CIs) were 1.80 (1.35–2.41), 3.42 (1.35–8.63), and 5.10 (1.93–13.45) for high, controlled, and uncontrolled BPs for low birth weight, respectively; 1.99 (1.48–2.68), 2.70 (1.12–6.50), and 6.53 (3.09–13.82) for high, controlled, and uncontrolled BPs for preterm birth, respectively; 1.64 (1.19–2.24), 2.17 (0.88–5.38), and 2.12 (0.80–5.65) for high, controlled, and uncontrolled BPs for admission to the Neonatal Intensive Care Unit or Growing Care Unit, respectively; and 1.17 (0.70–1.95), 2.23 (0.65–7.68), and 0.91 (0.20–4.16) for high, controlled, and uncontrolled BPs for 1-min Apgar score < 7, respectively. BP ≥ 140/90 mmHg might be taken care for preventing various adverse perinatal outcomes.

peripheral vascular disease

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the association between blood pressure control during pregnancy and adverse perinatal outcomes. Specifically, the study aims to investigate the effects of different blood pressure control states (normal blood pressure, hypertension, controlled blood pressure, and uncontrolled blood pressure) on the following adverse perinatal outcomes:

1. **Small for gestational age (SGA)**: Refers to a newborn whose birth weight is between the 1st and 10th percentiles of the weight distribution of infants of the same gestational age and gender.
2. **Low birth weight**: Defined as a newborn with a birth weight less than 2,500 grams.
3. **Preterm birth**: Defined as delivery before 37 weeks of gestation.
4. **Neonatal hospitalization**: Including admission to the pediatric ward, neonatal intensive care unit (NICU), or growth care unit (GCU).
5. **1 - minute Apgar score < 7**: The Apgar score is used to assess the health status of a newborn after birth, and a score of less than 7 at 1 minute may indicate that the newborn requires medical intervention.

### Research background
Hypertensive disorders during pregnancy increase the risk of many adverse perinatal outcomes, such as perinatal and fetal death, SGA, low birth weight, and preterm birth. Although blood pressure control is crucial for preventing these adverse outcomes, the blood pressure thresholds for hypertension treatment in different guidelines are not consistent. In addition, Japan has recently removed the contraindications for the use of certain antihypertensive drugs (such as amlodipine and nifedipine) in pregnant women, expanding the range of treatment options for blood pressure control during pregnancy. However, more evidence is still needed to support the specific impact of blood pressure control during pregnancy on perinatal outcomes.

### Research methods
The study used data from the TMM BirThree cohort study in Miyagi Prefecture, including a total of 18,155 mother - infant pairs. According to the blood pressure level after 20 weeks of pregnancy and whether antihypertensive drugs were used, pregnant women were divided into four groups:
- **Normal blood pressure**: < 140/90 mmHg and not using antihypertensive drugs.
- **Hypertension**: ≥ 140/90 mmHg and not using antihypertensive drugs.
- **Controlled blood pressure**: < 140/90 mmHg and using antihypertensive drugs.
- **Uncontrolled blood pressure**: ≥ 140/90 mmHg and using antihypertensive drugs.

Through multivariate logistic regression analysis, the study compared the incidences of SGA, low birth weight, preterm birth, neonatal hospitalization, and 1 - minute Apgar score < 7 among the groups, and calculated the adjusted odds ratios (ORs) and their 95% confidence intervals (CIs).

### Main findings
The study results showed that compared with normal blood pressure, hypertension, controlled blood pressure, and uncontrolled blood pressure were all associated with a higher risk of adverse perinatal outcomes. Specifically:
- In the hypertension group, the adjusted ORs (95% CI) were as follows: SGA 1.76 (1.32 - 2.35), low birth weight 1.80 (1.35 - 2.41), preterm birth 1.99 (1.48 - 2.68), neonatal hospitalization 1.87 (1.35 - 2.59).
- In the controlled blood pressure group, the adjusted ORs (95% CI) were as follows: SGA 2.08 (0.79 - 5.50), low birth weight 3.42 (1.35 - 8.63), preterm birth 2.70 (1.12 - 6.50), neonatal hospitalization 2.48 (0.79 - 7.80).
- In the uncontrolled blood pressure group, the adjusted ORs (95% CI) were as follows: SGA 2.34 (0.94 - 5.85), low birth weight 5.10 (1.93 - 13.45), preterm birth 6.53 (3.09 - 13.82), neonatal hospitalization 2.48 (0.79 - 7.80).

### Conclusion
The study indicates that blood pressure ≥ 140/90 mmHg during pregnancy may require special attention to prevent various adverse perinatal outcomes. In the future, more randomized controlled trials are needed to confirm the effectiveness of antihypertensive drugs during pregnancy on adverse maternal and neonatal outcomes.

### Asian perspective
The prevalence and severity of hypertension during pregnancy vary among different races. For example, the prevalence of chronic hypertension during pregnancy in Asian women is 1.6%, while it is 2.5% in American Indians or Alaska Natives, 5.1% in Blacks, 1.5% in Latinos, 2.9% in Native Hawaiians or other Pacific Islanders, 2.0% in Whites, and 2.3% in multi - racial or other races. In addition, the use rate of antihypertensive drugs during pregnancy in Asian countries such as Japan and South Korea is relatively low, reflecting the differences in the prevalence of hypertension during pregnancy.